The U.S. Food and Drug Administration (FDA) publicly announced in September 2019 that dangerously high levels of the carcinogenic substance N-Nitrosodimethylamine (NDMA) have been found in the popular over-the-counter heartburn medication, Zantac. This means that millions of people who have been taking Zantac have regularly been ingesting a chemical that is notorious for causing cancer.
Thousands of lawsuits are now being filed against the manufacturers of the blood thinner, Xarelto. These claims include that patients of Xarelto, have suffered serious injuries and even death as a product of taking the anti-coagulant drug. Specifically, they allege that the side effects of Xarelto include excessive and most importantly, uncontrollable bleeding which they were not sufficiently warned of by the makers of Xarelto. In fact, alarming questions are now being raised about the reliability in critical data of the type of testing that was used that ultimately led to Xarelto being approved for market use.
The defective drug, Xarelto, a blood thinner and anticoagulant drug manufactured to treat and prevent blood clots is now the source of thousands of lawsuits commenced against the drug's developers, Johnson & Johnson and Bayer.
Harmful drugs are recalled every month - meaning the drugs were available for public consumption and widespread use prior to a recall being issued by the U.S. Food and Drug Administration. A study released on June 4, 2012, found that the FDA's drug recall notification system is shockingly deficient in communicating the news of these recalls to doctors and patients, resulting in the continued use of dangerous products.
The antibiotic Zithromax, (azithromycin), commonly known as "Z-Pack," has been linked to increase the risk for deadly heart problems in users, according to a Vanderbilt University study published in the New England Journal of Medicine.